ZL-1310 trials for Lung cancer

All ZL-1310 trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying ZL-1310 for Lung cancer

• A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
  NCT07218146 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 155 locations
• A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
  NCT06179069 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 38 locations
• Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
  NCT07531095 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 27 locations

Common questions

How many trials study ZL-1310 for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.